Literature DB >> 19910793

Surgical interventions and local therapy for Wegener's granulomatosis.

José Hernández-Rodríguez1, Gary S Hoffman, Curry L Koening.   

Abstract

PURPOSE OF REVIEW: This review discusses the use of interventional procedures to treat manifestations of Wegener's granulomatosis caused by tissue damage and scarring. These manifestations include nasal and paranasal sinus disease, middle ear inflammation, nasolacrimal duct obstruction, orbital inflammatory masses, subglottic stenosis, tracheobronchial disease, and end-stage renal disease. RECENT
FINDINGS: Tissue damage caused by inflammation or a cicatricial process represents one of the major sources of morbidity for patients with Wegener's granulomatosis. Some of these manifestations require special interventions used alone or in combination with conventional medical treatment. These interventional procedures may include surgical or endoscopic repair of altered tissue, replacement of damaged organs, or the delivery of topical or injectable medications directly to the site of disease. Distinguishing symptoms caused by active disease from symptoms caused by tissue scarring is challenging and may play a critical role regarding the use of systemic immunosuppressive medications in combination with interventional therapy.
SUMMARY: Interventional procedures are indicated in certain manifestations of Wegener's granulomatosis. Distinguishing active Wegener's granulomatosis from inactive Wegener's granulomatosis and recognizing disease manifestations that may be amenable to local interventions can greatly improve the quality of life of patients. However, the evidence supporting the use of many of these interventions is based on small case series or individual reports.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19910793     DOI: 10.1097/BOR.0b013e328333e9e9

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  12 in total

1.  Update on the treatment of granulomatosis with polyangiitis (Wegener's).

Authors:  Carol A Langford
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-04

2.  Ear, nose and throat involvement in granulomatosis with polyangiitis: how it presents and how it determines disease severity and long-term outcomes.

Authors:  Mara Felicetti; Diego Cazzador; Roberto Padoan; Alfonso Luca Pendolino; Chiara Faccioli; Ennio Nardello; Alvise Berti; Marina Silvestrini; Giuseppe Paolazzi; Giuliano Brunori; Elisabetta Zanoletti; Enzo Emanuelli; Alessandro Martini; Franco Schiavon
Journal:  Clin Rheumatol       Date:  2018-02-20       Impact factor: 2.980

Review 3.  Nasoseptal Perforation: from Etiology to Treatment.

Authors:  Carla Pereira; Alfonso Santamaría; Cristobal Langdon; Mauricio López-Chacón; José Hernández-Rodríguez; Isam Alobid
Journal:  Curr Allergy Asthma Rep       Date:  2018-02-05       Impact factor: 4.806

4.  Missed Otological Presentation of Wegener's Granulomatosis: A Case.

Authors:  Ruchika Arora Grover; Ravneet Singh Grover
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2021-01-07

5.  Identifying relevant determinants of in-hospital time to diagnosis for ANCA-associated vasculitis patients.

Authors:  Ebru Dirikgil; Sander W Tas; Cornelis A Verburgh; Darius Soonawala; A Elisabeth Hak; Hilde H F Remmelts; Daphne IJpelaar; Gozewijn D Laverman; Abraham Rutgers; Jaap M van Laar; Hein J Bernelot Moens; Peter M J Verhoeven; Ton J Rabelink; Willem Jan W Bos; Y K Onno Teng
Journal:  Rheumatol Adv Pract       Date:  2022-06-09

Review 6.  The role of surgery in antineutrophil cytoplasmic antibody-associated vasculitides affecting the nose and sinuses: A systematic review.

Authors:  Alfonso Luca Pendolino; Samit Unadkat; Henry Zhang; Monica Pendolino; Gerolamo Bianchi; Premjit S Randhawa; Peter J Andrews
Journal:  SAGE Open Med       Date:  2020-07-01

Review 7.  Granulomatosis with polyangiitis (Wegener's disease): An updated review of ocular disease manifestations.

Authors:  Buraa Kubaisi; Khawla Abu Samra; C Stephen Foster
Journal:  Intractable Rare Dis Res       Date:  2016-05

Review 8.  Current and emerging treatment options for ANCA-associated vasculitis: potential role of belimumab and other BAFF/APRIL targeting agents.

Authors:  Aleksander Lenert; Petar Lenert
Journal:  Drug Des Devel Ther       Date:  2015-01-07       Impact factor: 4.162

9.  Granulomatosis with polyangiitis with obstructive pneumonia progressing to hypertrophic pachymeningitis: A case report.

Authors:  Keigo Hayashi; Haruki Watanabe; Yuriko Yamamura; Yosuke Asano; Yu Katayama; Sumie Hiramatsu-Asano; Keiji Ohashi; Michiko Morishita; Mariko Narazaki; Yoshinori Matsumoto; Ken-Ei Sada; Jun Wada
Journal:  Medicine (Baltimore)       Date:  2021-01-22       Impact factor: 1.889

10.  Tracheobronchial Stenoses in Granulomatosis With Polyangiitis (Wegener's): A Report on 26 Cases.

Authors:  Charlotte Girard; Pierre Charles; Benjamin Terrier; Guillaume Bussonne; Pascal Cohen; Christian Pagnoux; Vincent Cottin; Jean-François Cordier; Loïc Guillevin
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.